Literature DB >> 6368590

Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

R W Milne, P K Weech, L Blanchette, J Davignon, P Alaupovic, Y L Marcel.   

Abstract

Two major species of human apolipoprotein (apo) B have been identified, apo B-48 and apo B-100, which are the predominant forms in chylomicrons and very low density lipoproteins (VLDL), respectively. Due to defective hepatic clearance, apo B-48 containing lipoproteins accumulate in the plasma of subjects with type III hyperlipoproteinemia. In the present study, we have used immunoaffinity chromatography to separate type III VLDL into a nonretained (apo B-48 VLDL) and a retained (apo B-100 VLDL) fraction. To achieve complete separation, as determined by electrophoresis and radioimmunoassay, it was necessary to employ two different insolubilized anti-apo B-100 monoclonal antibodies because of immunochemical heterogeneity within the apo B-100 VLDL fraction. The ability to separate apo B-100 VLDL from apo B-48 VLDL shows that the two apo B species are found on different particles. The apo B-48 VLDL had an electrophoretic mobility similar to chylomicrons, whereas the apo B-100 VLDL migrated similarly to total type III VLDL. Both fractions showed a concentration of particles with diameters approximately 100 nm, with apo B-48 VLDL being somewhat more heterogeneous in particle size. The two fractions were qualitatively similar in apolipoprotein composition but apo B-48 VLDL was enriched in apo E, relative to apo B-100 VLDL. Apo B-48 VLDL was enriched in cholesterol esters and deficient in triglycerides and phospholipids when compared with apo B-100 VLDL. The existence of immunochemical heterogeneity in the apo B-100 VLDL may reflect different functional subpopulations of particles within this fraction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368590      PMCID: PMC425085          DOI: 10.1172/JCI111276

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis.

Authors:  A Kuksis; J J Myher; L Marai; K Geher
Journal:  J Chromatogr Sci       Date:  1975-09       Impact factor: 1.618

2.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.

Authors:  G Utermann; M Hees; A Steinmetz
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

3.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.

Authors:  M Berman; M Hall; R I Levy; S Eisenberg; D W Bilheimer; R D Phair; R H Goebel
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

4.  A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.

Authors:  J P Kane
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

Authors:  M D Curry; P Alaupovic; C A Suenram
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

8.  Determination of human apolipoprotein E by electroimmunoassay.

Authors:  M D Curry; W J McConathy; P Alaupovic; J H Ledford; M Popović
Journal:  Biochim Biophys Acta       Date:  1976-08-09

9.  Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).

Authors:  W R Hazzard; E L Bierman
Journal:  Metabolism       Date:  1976-07       Impact factor: 8.694

10.  Comparison of the serum low density lipoprotein and of its apoprotein in the pig, rhesus monkey and baboon with that in man.

Authors:  M J Chapman; S Goldstein
Journal:  Atherosclerosis       Date:  1976 Nov-Dec       Impact factor: 5.162

View more
  10 in total

1.  Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  R V Farese; M M Véniant; C M Cham; L M Flynn; V Pierotti; J F Loring; M Traber; S Ruland; R S Stokowski; D Huszar; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Development and partial characterisation of an antiserum against apolipoprotein B of the short-finned eel, Anguilla australis.

Authors:  Erin L Damsteegt; Hiroko Mizuta; Yuichi Ozaki; Naoshi Hiramatsu; Takashi Todo; Akihiko Hara; Shigeho Ijiri; Shinji Adachi; P Mark Lokman
Journal:  J Comp Physiol B       Date:  2014-03-11       Impact factor: 2.200

3.  Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

5.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.

Authors:  T L Innerarity; S G Young; K S Poksay; R W Mahley; R S Smith; R W Milne; Y L Marcel; K H Weisgraber
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  Effect of chylomicron remnants on cholesterol metabolism in cultured rabbit hepatocytes: very low density lipoprotein and bile acid production.

Authors:  V A Kosykh; D K Novikov; I N Trakht; E A Podrez; A V Victorov; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1991-10       Impact factor: 1.880

8.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Authors:  M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

9.  Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

Authors:  S G Young; S J Bertics; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.

Authors:  P N Herbert; J S Hyams; D N Bernier; M M Berman; A L Saritelli; K M Lynch; A V Nichols; T M Forte
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.